Gross margin guided to 14-16% while operating cash flow covers 14% of quarterly capex. ROE is 1.2%.
Thesis: Hua Hong is posting genuine beat-and-raise with 13% gross margin up 380bps YoY and guided 14-16% next quarter. But the entire price increase thesis rests on a memory supply imbalance that Chairman Bai explicitly said he will stop exploiting when it normalizes. Meanwhile capex of $925M against $130M OCF is being funded by $649M of fresh debt, pushing interest-bearing borrowings from $3.19B to $3.90B in one quarter with 1.2% annualized ROE. The revenue line is real. The capital allocation is destroying value.
Verdict: AVOID — Conviction: MEDIUM
Catalyst: Memory supply-demand balance normalizing, which Chairman Bai says will trigger a stop to price increases. Fab 9A full output by year end would confirm capacity ramp but also expose the pricing reversal.
Key Risk: Export controls severing 79.5% China revenue. Management says 'not an issue' but qualifies with 'we certainly hope this environment is gonna be further relaxed.' A policy shift is binary and unquantifiable.
The Tell: Chairman Bai, unprompted: 'We will stop price increases when the supply-demand balance is reached.' He volunteered that his pricing power is entirely conditional and self-terminating. The entire margin expansion thesis rests on a supply imbalance he's telling you will resolve.
Friction Level: MODERATE_FRICTION — Both sides agree on the beat-and-raise and margin trajectory. Disagreement centers on whether 10-15% price increases are structural or cycle-dependent. Chairman Bai himself says they stop when supply-demand balances, which makes pricing power explicitly temporary.
Report not found
The report data is no longer available. Please return to the archive.